SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
KL Chai, E Tomlinson, Z Khosravi… - Cochrane Database …, 2021 - cochranelibrary.com
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
N Kreuzberger, C Hirsch, KL Chai… - Cochrane Database …, 2021 - research.monash.edu
Background: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
N Kreuzberger, C Hirsch, KL Chai… - The Cochrane …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from
the B cells of an infected host. They are being investigated as a potential therapy for …
the B cells of an infected host. They are being investigated as a potential therapy for …
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
N Kreuzberger, C Hirsch, KL Chai… - The Cochrane …, 2021 - researchportal.ukhsa.gov.uk
Background: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
N Kreuzberger, C Hirsch, KL Chai… - Cochrane Database of …, 2021 - ora.ox.ac.uk
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
[HTML][HTML] SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
N Kreuzberger, C Hirsch… - Cochrane …, 2021 - research-information.bris.ac.uk
Background: Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
N Kreuzberger, C Hirsch, KL Chai… - The Cochrane …, 2021 - europepmc.org
Background Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from
the B cells of an infected host. They are being investigated as a potential therapy for …
the B cells of an infected host. They are being investigated as a potential therapy for …
[HTML][HTML] SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
N Kreuzberger, C Hirsch, KL Chai… - The Cochrane …, 2021 - ncbi.nlm.nih.gov
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
KL Chai, E Tomlinson, Z Khosravi… - Cochrane Database …, 2021 - cochranelibrary.com
Hintergrund Monoklonale Antikörper (mAks) sind im Labor hergestellte Moleküle, die aus
den B‐Zellen eines infizierten Wirts abgeleitet werden. Sie werden als mögliche Therapie …
den B‐Zellen eines infizierten Wirts abgeleitet werden. Sie werden als mögliche Therapie …
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
N Kreuzberger, C Hirsch, KL Chai, E Tomlinson… - 2021 - mediatum.ub.tum.de
BACKGROUND: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …